Insulin degrading enzyme (IDE) is believed to act as a junction point of Type 2 diabetes (T2D) and Alzheimer's disease (AD); however, the underlying mechanism was not completely clear yet. The gene discussed is IDE; the disease is early-onset autosomal dominant Alzheimer disease.